USC recently opened the USC Stevens Hall for Neuroimaging, the new home for the Mark and Mary Stevens Neuroimaging and Informatics Institute. The sleek, modern, state-of-the-art research building is located on the southern edge of USC's Health Sciences Campus and will help accelerate research on neurological disorders such as autism and Alzheimer’s Disease.Read More
Researchers and clinicians at the newly renamed University of Southern California's Epstein Family Center for Sports Medicine will collaborate with the university’s Athletics Department and the Keck School of Medicine to develop innovative injury prevention strategies to not only keep Trojan student-athletes healthy, but also help predict the risk of injury and reinjury. $10,000,000 recently donated by the Epstein Family Foundation will help USC staff achieve this.
Two USC stem cell researchers have received a combined $4 million from the National Institute of Health (NIH). Dr. Qi-Long Ying will oversee a $1.32 million grant focusing on how two specific proteins influence whether stem cells self-renew to produce additional stem cells or become more specialized cell types. A $2.82 million grant awarded to Dr. Neil Segil will explore why humans are unable to recover from hearing loss, while birds and reptiles can.Read More
Tags: CA, University of Southern California, California, USC, Southwest Region, stem cell research market, Biotech Vendor Showcase, laboratory suppliers, New research center, stem cell science, Biotech Showcase 2018
Does your Lab Equipment and Product Territory Include Texas?
The Texas Medical Center has recently fostered a $25 million initiative designed to support technologies and early-stage companies and to further the TMC’s mission to advance health, education and research.
"The Texas Medical Center unveiled plans for the TMC Venture Fund to an audience of more than 600 investors, hospital stakeholders, advisors and members of Houston’s innovation ecosystem" see press release. For those wondering just how big this is compared to the overall Texas Medical Center research marketplace, current estimates for the size of this market range from $1.8 Billion to $2.2 Billion.
Tags: Biotech Event, Texas Medical Center, Texas, Healthcare, tmc, Biotechnology, TX, lab equipment, Southwest Region, Biotech vendor, Lab Sales, Lab Supply, best lab supply tradeshows, best science tradeshows, BioResearch Product Faire™
UC Davis has a long history of ground breaking stem cell research. Possible therapies studied range from advanced wound healing, treating HIV, and reduced vision loss to the regeneration of bone in otherwise non-healing fractures. Now The California Institute for Regenerative Medicine (CIRM) has awarded UC Davis Medical Center scientists nearly $8 million in research funding to launch a special clinical trials program in Sacramento. The goal of the grant is to accelerate the development and delivery of stem cell therapies in human patients.Read More
Tags: CA, Current Biotechnology Events, immunotherapy, Stem cell research, Human Stem Cell, California, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, BioResearch Product Faire, Bioresearch Grant, Laboratory product sales, laboratory tools
UC Davis Medical Center’s Mind Institute was one of five institutes in the nation to win the NIH’s Autism Centers of Excellence Award (ACE). The $12 million, five year grant, will be used for the creation of the “Center for the Development of Phenotype-based Treatments of Autism Spectrum Disorder.” This new center will take a personalize approach to addressing autism spectrum disorder (ASD) treatment based on a child’s behavioral and biological characteristics. The goal will be to identify and tailor treatments that improve the quality of life for those with ASD.Read More
Tags: CA, Current Biotechnology Events, California, NIH funded Research Projects, Autism, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, drug evaluation, BioResearch Product Faire, autism research, Bioresearch Grant, Laboratory product sales, NIH awards 2017
About 1 in every 100 babies born have a congenital heart defect (CHD), a structural defect of the heart. In fact, CHDs are the most common types of birth defect. In one quarter of the cases the condition is serious enough to require surgery or other procedures within the first year of life. Despite the frequency, the cause of most congenital heart defects remains a mystery. And without knowing the cause, scientists are not been able to find a way of preventing these defects.Read More
Currently, there are no FDA approved medications for treating fragile X syndrome. That may soon change, thanks to a $11.5 million NIH grant awarded to UC Davis Medical Center. The new funding will allow researchers to test a new drug that is designed to improve language learning for children with fragile X syndrome. UC Davis is one of only two medical centers approved for the drug trail in the nation. Since UC Davis Medical Center is home to the renowned MIND Institute, which hosts the Fragile X Research and Treatment Center, it is a logical choice for the treatment study.Read More
Tags: CA, California, Research Funding, Drug Development, research grant, UC Davis - Medical Center, Southwest Region, new research grant, UCD, drug evaluation, BioResearch Product Faire, Bioresearch Grant
USC recently opened the USC Stevens Hall for Neuroimaging, the new home for the Mark and Mary Stevens Neuroimaging and Informatics Institute. The sleek, modern, state-of-the-art research building is located on the southern edge of USC's Health Sciences Campus and will help accelerate research on neurologic disorders such as autism and Alzheimer’s Disease.Read More
Researchers at Texas Medical Center’s Rice University recently discovered that Huntington’s Disease might be triggered by a repeating nucleotide sequence in the gene for a mutant protein. The research team conducted this study by analyzing proteins that were suspected to misfold and form plaques in the brains of patients with neurological diseases.Read More